Terry Dagnon, Chief Operating Officer at Outlook Therapeutics, Inc. (OTLK), sold 63,700 shares at $2.55 ($162K) on 2021-02-12, disclosed to the SEC on 2021-02-17.
Open-market sale of $162k OTLK by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| OTLK | BUY | 2021-12-06 | $35K | — | Filing → |
| OTLK | BUY | 2021-12-03 | $14K | — | Filing → |
| OTLK | SELL | 2021-02-25 | $33K | — | Filing → |